Upgrade to SI Premium - Free Trial

Medpace (MEDP) PT Lowered to $462 at Truist Securities

April 24, 2026 4:26 AM
Truist Securities analyst Jailendra Singh lowered the price target on Medpace (NASDAQ: MEDP) to $462.00 (from $539.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change